Holdings (as at 2026-06-03)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.99%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2026-06-03)
Security Name % of Net Assets
Corcept Therapeutics Inc. 5.24%
Bruker Corporation 5.05%
Veracyte, Inc. 4.74%
Illumina, Inc. 4.28%
NeoGenomics, Inc. 3.99%
Axsome Therapeutics, Inc. 3.97%
Alkermes Plc 3.88%
Neurocrine Biosciences, Inc. 3.88%
Exelixis, Inc. 3.53%
Krystal Biotech, Inc. 3.53%
Biogen Inc. 3.43%
Arrowhead Pharmaceuticals, Inc. 3.37%
Natera, Inc. 3.32%
Halozyme Therapeutics, Inc. 3.11%
Incyte Corporation 3.09%
argenx SE (ADR) 3.08%
Repligen Corporation 3.07%
BioMarin Pharmaceutical Inc. 3.03%
Vertex Pharmaceuticals Incorporated 2.97%
Amgen Inc. 2.92%
United Therapeutics Corporation 2.91%
Gilead Sciences, Inc. 2.81%
BioNTech SE (ADR) 2.80%
Bio-Techne Corporation 2.77%
Alnylam Pharmaceuticals, Inc. 2.75%
BeOne Medicines Ltd. (ADR) 2.73%
Genmab A/S (ADR) 2.56%
Regeneron Pharmaceuticals, Inc. 2.50%
ADMA Biologics, Inc. 2.42%
Sarepta Therapeutics, Inc. 2.32%
Dreyfus Government Cash Management (Institutional Shares) 0.04%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.